Practice Quiz

Medical Assistant NCMA Practice Test - Question List

Select how would you like to study

Study Mode Free Daily Question Test Mode
61. Which of the following is an appropriate agent and dosing schedule for a newly diagnosed patient with gout?
  1. Acarbose, 100mg, PO, tid
  2. Alitretinoin, 0.1% topical gel, qid
  3. Hydroxycobalamin, 500mcg, PO, qd
  4. Allopurinol, 200 mg PO, qd
See answer
62. In the hazard identification system, four small color-coded diamonds are grouped into a larger diamond. Numbers represent the severity of the hazard. What would the yellow diamond with the number 4 indicate?
  1. Yellow indicates a reactivity/stability hazard. The number 4 indicates no hazard.
  2. Yellow indicates a reactivity/stability hazard. The number 4 indicates extreme hazard.
  3. Yellow indicates a special hazard. The number 4 indicates a moderate hazard.
  4. Yellow indicates a flammability hazard. The number 4 indicates a mild hazard.
See answer
63.

A patient that is newly diagnosed with multiple sclerosis (MS) is concerned about the interferon-beta injections she was told to give herself. What would you want to make her aware of concerning adverse reactions?

I. The most common adverse reactions involve the injection site and include pain, redness and soreness.
II. Keep the syringe in the refrigerator, rotate the areas where you inject and use NSAIDS for any flu-like symptoms.
III. The most serious adverse reactions concern suicidal ideation, cardiac arrhythmias, blood abnormalities and intestinal obstruction.

  1. Both I and II are correct
  2. Both II and III are correct
  3. Only I and III are correct
  4. All are correct
See answer
64. Which of the following may cause false negative blood culture results?
  1. Not enough blood collected.
  2. Air injected into anaerobic collection bottle.
  3. Iodine-contamination of sample.
  4. All of the above.
See answer
65. You are working in a university hospital setting where many patients are enrolled in clinical trials. Which of the following statements is true concerning Phase I, II or III clinical trials?
  1. A phase I trial is often very small (N<30) and seeks to determine the safe dose range for a new drug.
  2. A phase II trial is often larger than a phase I trial and seeks to determine if a new drug is effective enough to test in a phase III trial and to delineate adverse effects.
  3. A Phase III trial compares a new treatment with an established treatment and is usually much larger than either a phase I or a phase II trial.
  4. All three of the statements are correct.
See answer

Select how would you like to study

Study Mode Free Daily Question Test Mode